Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.22
0.19 (6.27%)
At close: Aug 18, 2025, 3:59 PM
3.17
-1.55%
After-hours: Aug 18, 2025, 06:50 PM EDT
6.27% (1D)
| Bid | 2.96 |
| Market Cap | 124.23M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -45.41M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -2.06 |
| Forward PE | -1.86 |
| Analyst | Buy |
| Ask | 3.76 |
| Volume | 123,405 |
| Avg. Volume (20D) | 316,367 |
| Open | 3.07 |
| Previous Close | 3.03 |
| Day's Range | 3.05 - 3.23 |
| 52-Week Range | 1.59 - 10.48 |
| Beta | 1.42 |
About TARA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-18.52%
Protara Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
3 months ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.
